Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 2003, p. 775-779, Vol. 10, No. 5
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.5.775-779.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Decanato de Medicina, Universidad Centroccidental "Lisandro Alvarado," Barquisimeto 3001,1 Instituto de Estudios Avanzados, Ministerio de Ciencia y Tecnología, Caracas,2 Investigaciones Parasitológicas "José Francisco Torrealba," Universidad de Los Andes, Mérida,3 Instituto de Biología Experimental, Universidad Central de Venezuela, 1041-A Caracas, Venezuela4
Received 30 January 2003/ Returned for modification 31 March 2003/ Accepted 10 June 2003
|
|
|---|
|
|
|---|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. T. cruzi and T. rangeli strains, isolates, and clones used in this work
|
DNA samples for titration of duplex PCR. For titration of the duplex amplification reactions (see Fig. 4), DNA was released from parasites by diluting 105 epimastigote cells in 100 µl of 10 mM Tris (pH 7.5)-150 mM NaCl and boiling the cell suspension for 10 min.
![]() View larger version (62K): [in a new window] |
FIG. 4. T. cruzi/T. rangeli duplex PCR assay titration experiment. Lanes 2 to 8, PCR products obtained from serial dilutions of lysed parasites in the following T. rangeli DOG-82/T. cruzi CL Brener ratios: lane 2, 0/105; lane 3, 100/104; lane 4, 101/103; lane 5, 102/102; lane 6, 103/101; lane 7, 104/100; lane 8, 105/0. Lanes 1 and 9 contain a 100-bp size ladder (Gibco-BRL).
|
Experimental mice were infected by an intradermic injection of 105 T. cruzi blood trypomastigotes. After 15 days, mice were sacrificed, and their hearts were removed and preserved at -20°C. To simulate infected mouse blood for additional experiments, 5 x 106 epimastigotes of T. cruzi, T. rangeli, or both were mixed with 1 ml of blood.
Preparation of samples for duplex PCR. For blood samples collected on filter paper, 6-mm-diameter filter disks were cut and placed in Eppendorf microtubes with 100 µl of distilled sterile water. In the case of heart biopsies, approximately 2 mm3 of material was used in place of the filter disks. All samples were incubated with 5 µl of 20-mg/ml proteinase K (Promega) at 56°C for 30 min. After boiling for 10 min, Chelex-100 (Bio-Rad) was added to a final concentration of 10%, and the mixture was boiled again for 15 min. The samples were centrifuged at 12,000 rpm for 20 min, and the supernatant was transferred to a fresh tube, phenol-chloroform extracted, and precipitated with 99% ethanol plus 1 µl of 2% glycogen. Precipitated DNA was resuspended in 30 µl of H2O and stored at -20°C.
PCR conditions. For T. cruzi detection, we used a modified version of a PCR assay targeted to the 189-bp telomeric junction (Tc189, GenBank accession number AF100651) (Fig. 1) (11). The primers were T189Fw2 (5'-CCAACGCTCCGGGAAAAC-3') and Tc189Rv3 (5'-GCGTCTTCTCAGTATGGACTT-3'). For T. rangeli detection, we used an assay targeted to a conserved subtelomeric region (SubTr, GenBank accession number AF426020) (8) (Fig. 1). The primers were TrF3 (5'-CCCCATACAAAACACCCTT-3') and TrR8 (5'-TGGAATGACGGTGCGGCGAC-3'). All oligonucleotides were purchased from Operon Technologies, Inc., Alameda, Calif. Single PCR amplifications were conducted in a final volume of 25 µl containing 0.2 mM deoxynucleoside triphosphate mixture, 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% Triton X-100, 0.4 µM each of the forward and reverse primers, 1.25 U of Taq DNA polymerase (Promega), and 1 to 10 ng of purified DNA template. An initial denaturation step at 94°C for 4 min was followed by 35 cycles of 30 s at 55°C, 40 s at 72°C, and 1 min at 94°C. This amplification was followed by incubations of 1 min at 55°C and 3 min at 72°C. Amplification was confirmed in a 2% agarose gel stained with ethidium bromide.
![]() View larger version (24K): [in a new window] |
FIG. 1. Schematic representation of T. cruzi and T. rangeli telomeric organization. Horizontal bars indicate the regions amplified by each set of primers. SubTr, T. rangeli conserved subtelomeric region. Blocks grouped with parentheses are sequences related to the T. cruzi trans-sialidase (TSA) superfamily.
|
For Southern blotting, gel-separated PCR products were transferred to nylon filters (Hybond-N; Amersham-Pharmacia-Biotech), UV cross-linked, dried, and stored until used.
Labeling and hybridizations with capture oligonucleotides. For confirmatory hybridization experiments, we designed the following capture oligonucleotides: Tc189cap (5'-GCTCAAACACACTACACAAAG-3') for the T. cruzi assay and Trcap (5'-CGGTAAAGCGAGTTTTGGT-3') for the T. rangeli assay.
These oligonucleotides were labeled with dUTP-digoxigenin tails synthesized by terminal deoxynucleotidyl transferase as described previously (15). Hybridizations were carried out in 5x SSC (0.75 M NaCl, 0.075 M sodium citrate [pH 7.0], 0.1% sodium-N-laurylsarcosinate, 0.02% SDS, and 1% blocking reagent [Boehringer Mannheim]) at 55°C for 3 h. After hybridization, filters were washed at room temperature in 6x SSC-0.1% SDS for 5 min, then washed with 2x SSC-0.1% SDS at room temperature for 15 min, and finally washed at 58°C for 15 min with the same solution. Hybridized probes were detected by chemiluminescence with Lumi Phos 530, according to the manufacturer's instructions (Boehringer Mannheim).
|
|
|---|
![]() View larger version (73K): [in a new window] |
FIG. 2. PCR amplification of the T. cruzi Tc189-specific sequence. (A) Agarose gel electrophoresis of amplified products obtained with primers Tc189 Fw2 and Tc189 Rv3. (B) Southern blot of gel A after hybridization with digoxigenin-labeled Tc189cap oligonucleotide. Lanes: 1, T. cruzi CL Brener; 2, T. cruzi CL; 3, T. cruzi G; 4, T. cruzi Y; 5, T. cruzi Tulahuen; 6, T. cruzi Dm 28c; 7, T. cruzi Dm 30c; 8, T. cruzi Maracay; 9, T. cruzi JMP; 10, T. rangeli DOG-82; 11, T. rangeli Triat 1; 12, T. rangeli S. Agustín; 13, T. rangeli Mono; 14, T. rangeli Alba; 15, L. chagasi; 16, L. braziliensis; 17, C. fasciculata; 18, recombinant TcVA17 (positive control) (9); 19, H2O. Arrow indicates the 100-bp specific product.
|
![]() View larger version (69K): [in a new window] |
FIG. 3. PCR amplification of T. rangeli SubTr-specific sequence. (A) Agarose gel electrophoresis of amplified products with TrF3 and TrRv6 primers. (B) Southern blot of gel A after hybridization with digoxigenin-labeled Trcap oligonucleotide. Lanes: 1, T. rangeli DOG-82; 2, T. rangeli triat 1; 3, T. rangeli triat 2; 4, T. rangeli S. Agustín; 5, T. rangeli Palma, 6, T. rangeli JRM; 7, T. rangeli Alba; 8, T. cruzi CL Brener; 9, T. cruzi G; 10, T. cruzi JMP; 11, T. rangeli Mono; 12, Trypanosoma sp. 13, Trypanosoma saimirii; 14, T. lewisi; 15, T. evansi; 16, L. amazonensis; 17, L. braziliensis; 18, L. chagasi; 19, C. fasciculata; 20, Recombinant TrVA5 (8) (positive control). Arrow indicates the 170-bp specific product.
|
Duplex PCR assay. Once the optimal conditions were established for the individual PCR assays, we combined them in a duplex assay and tested the sensitivity of this assay against a gradient of DNA concentrations from each parasite. As shown in Fig. 4, DNA was extracted from 105 cells of each parasite and sequentially diluted by factors of 10. DNA dilutions from the two parasites were mixed in inverted concentration ratios, so that the highest amount for one parasite, 105 cells per approximately 20 ng, matched the lowest dilution of the other (0, the negative control for reagents).
Duplex PCR yielded specific, appropriately sized amplification products from each reaction with no apparent primer interference (Fig. 4, lanes 2 to 8). Under these conditions, the assay detected DNA equivalent to a single cell.
Duplex PCR assay in other samples. Next, we tested the ability of the duplex PCR assay to detect both parasites together within various samples (Fig. 5). The duplex assay was able to appropriately detect the presence of cultured T. cruzi (lane 2), T. rangeli (lane 3), and a mix of the two (lane 4). Experimentally infected triatomine feces were successfully identified as uninfected (lane 5), infected with T. cruzi (lane 6), or infected with both parasites (lane 7). Dissected intestinal tracts of triatomine bugs were PCR identified as coming from an uninfected bug (negative control, lane 8), from R. prolixus experimentally infected with T. cruzi (lane 9), and with both parasites (lane 11). In addition, a triatomine bug captured from the wild (Barinas State, Venezuela) tested positive for both parasites (lane 10). Further testing of the PCR assay's applicability showed that it was capable of distinguishing the presence and absence of the parasites in mouse blood in which infection of T. cruzi and/or T. rangeli was simulated (lanes 12 to 15), as well as in mouse heart samples from noninfected (negative control, lane 16) and T. cruzi-infected animals (15 days postinfection; lane 17). Finally, we tested a blood sample from a human subject living in an area where the disease is endemic, confirming the presence of both parasites in this patient, who was parasitologically and serologically positive for T. cruzi and T. rangeli (lane 19).
![]() View larger version (51K): [in a new window] |
FIG. 5. Duplex PCR in different samples visualized in ethidium bromide-stained 3% agarose gels. Cultured parasite cells, lanes: 2, T. cruzi; 3, T. rangeli; 4, T. cruzi + T. rangeli. R. prolixus feces, lanes: 5, noninfected; 6, infected with T. cruzi, 7, infected with T. cruzi plus T. rangeli. R. prolixus intestinal tract, lanes: 8, noninfected; 9, infected with T. cruzi; 10, T. rangeli; 11, T. cruzi plus T. rangeli. Simulated mice blood infections, lanes: 12, noninfected; 13, infected with T. cruzi; 14, infected with T. rangeli; 15, infected with T. cruzi plus T. rangeli. Mouse heart samples, lanes: 16, noninfected; 17, infected with T. cruzi. Lane 18, H2O. Lane 19, blood from a human case. Lanes 1 and 20 are the 100-bp size ladder (Gibco-BRL). Arrows indicate 100- and 170-bp specific amplification products for T. cruzi and T. rangeli, respectively.
|
|
|
|---|
However, despite the minor bands present in the T. rangeli assay, we were able to duplex this reaction with the T. cruzi-specific assay and produce specific, correct amplification products. No amplification artifacts due to primer interference were observed even in samples with a large excess of DNA from one parasite over the other. The duplex assay was capable of detecting as little as one parasitic cell of each species in the samples tested. In additional experiments with parasite cell dilutions without confirmatory hybridization experiments (not shown), we detected an equivalent to 1/20th and 1/4th of T. cruzi and T. rangeli cells, respectively. This difference in detection level is likely due to a smaller number of telomeric targets in T. rangeli, as can be deduced from the smaller number of chromosomal bands exhibited by this organism in pulsed-field electrophoresis experiments (17). Importantly, the sensitivity reached by our duplex PCR in field samples is similar to that reported for single T. rangeli PCR typing assays with primers targeted to other nuclear targets (16, 21, 24, 29).
In the study of mixed infections, parasite culturing can cause the selection of one parasite over the other; hence, it is desirable to be able to analyze field samples directly. However, the presence of Taq DNA polymerase inhibitors in this type of sample poses a major problem for most PCR assays. A multiplex assay based on miniexon spacer sequences has been used to type T. cruzi and T. rangeli cells in culture (14). Another multiplex assay, targeted to the large-subunit rRNA gene, has been applied to detect these parasites in simulated infected vectors and in culture (24, 29). However, these assays have not been used previously to detect parasites in vertebrate blood. A related PCR assay based on kinetoplast DNA was highly sensitive for both trypanosomes, but the small size differences of the PCR products made it impractical to study mixed infections (28).
Therefore, to our knowledge this is the first report of a duplex PCR assay based on different DNA targets for the simultaneous detection of T. cruzi and T. rangeli. Our method ensures the simple, independent amplification of both targets and in addition is specific and robust enough to be used directly in the field and on complex samples. The duplex assay has the additional advantage of not requiring confirmatory hybridization experiments, and we are currently using it to examine patient blood and triatomine vector samples from an area in Barinas State, Venezuela, where T. rangeli infections greatly exceed those of T. cruzi (3). This method may allow the proper diagnosis of infections, allowing fewer false-positives and the attendant risk of chemotherapy.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»